BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31907866)

  • 1. Phenotypic Differences in Primary Murine Microglia Treated with NOD1, NOD2, and NOD1/2 Agonists.
    Wasmuth S; Jalilvand TV; Laffer B; Busch M; Bauer D; Langmann T; Thanos S; Kasper M; Heiligenhaus A
    J Mol Neurosci; 2020 Apr; 70(4):600-609. PubMed ID: 31907866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
    Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
    Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice.
    Sato T; Shikama Y; Shimauchi H; Endo Y; Takada H
    Innate Immun; 2011 Feb; 17(1):54-9. PubMed ID: 20083500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
    Tada H; Aiba S; Shibata K; Ohteki T; Takada H
    Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.
    Kvarnhammar AM; Petterson T; Cardell LO
    Immunology; 2011 Nov; 134(3):314-25. PubMed ID: 21978001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs.
    Park JH; Kim YG; McDonald C; Kanneganti TD; Hasegawa M; Body-Malapel M; Inohara N; Núñez G
    J Immunol; 2007 Feb; 178(4):2380-6. PubMed ID: 17277144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
    van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
    Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers.
    Farzi A; Reichmann F; Meinitzer A; Mayerhofer R; Jain P; Hassan AM; Fröhlich EE; Wagner K; Painsipp E; Rinner B; Holzer P
    Brain Behav Immun; 2015 Feb; 44():106-20. PubMed ID: 25218901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide-binding oligomerization domain 2 (NOD2) activation induces apoptosis of human oral squamous cell carcinoma cells.
    Yoon HE; Ahn MY; Kwon SM; Kim DJ; Lee J; Yoon JH
    J Oral Pathol Med; 2016 Apr; 45(4):262-7. PubMed ID: 26332444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma.
    Wong CK; Hu S; Leung KM; Dong J; He L; Chu YJ; Chu IM; Qiu HN; Liu KY; Lam CW
    Cell Mol Immunol; 2013 Jul; 10(4):317-29. PubMed ID: 23524653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
    Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
    Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular adhesion molecule-1 is regulated by porphyromonas gingivalis through nucleotide binding oligomerization domain-containing proteins 1 and 2 molecules in periodontal fibroblasts.
    Liu J; Duan J; Wang Y; Ouyang X
    J Periodontol; 2014 Feb; 85(2):358-68. PubMed ID: 23688098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue.
    Dagil YA; Arbatsky NP; Alkhazova BI; L'vov VL; Mazurov DV; Pashenkov MV
    PLoS One; 2016; 11(8):e0160784. PubMed ID: 27513337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD1 and NOD2 stimulation triggers innate immune responses of human periodontal ligament cells.
    Jeon DI; Park SR; Ahn MY; Ahn SG; Park JH; Yoon JH
    Int J Mol Med; 2012 Apr; 29(4):699-703. PubMed ID: 22218461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway.
    Werts C; le Bourhis L; Liu J; Magalhaes JG; Carneiro LA; Fritz JH; Stockinger S; Balloy V; Chignard M; Decker T; Philpott DJ; Ma X; Girardin SE
    Eur J Immunol; 2007 Sep; 37(9):2499-508. PubMed ID: 17705131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Nod1 signaling in corneal neovascularization.
    Kim SJ; Lee JW; Yeo ED; Yu SL; Jean WS; Kim JH; Park CG; Lee HY; Han SY; Park JH; Ko BY; Kang J
    Cornea; 2013 May; 32(5):674-9. PubMed ID: 23328697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo.
    Cartwright N; Murch O; McMaster SK; Paul-Clark MJ; van Heel DA; Ryffel B; Quesniaux VF; Evans TW; Thiemermann C; Mitchell JA
    Am J Respir Crit Care Med; 2007 Mar; 175(6):595-603. PubMed ID: 17234906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of NOD receptor ligands as immunomodulators in particulate vaccine carriers.
    Wischke C; Mathew S; Roch T; Frentsch M; Lendlein A
    J Control Release; 2012 Dec; 164(3):299-306. PubMed ID: 22771980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
    Fritz JH; Girardin SE; Fitting C; Werts C; Mengin-Lecreulx D; Caroff M; Cavaillon JM; Philpott DJ; Adib-Conquy M
    Eur J Immunol; 2005 Aug; 35(8):2459-70. PubMed ID: 16021602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.